Table 5.
Factors associated with level of HCV viremia among HIV-infected women at baseline WIHS visit, multivariate ordinal logistic regression analyses using log HCV RNA level >0 to <5.0 as reference levela
No. of participants by HCV RNA Level (log10 copies/ml) | HCV RNA Level (log10 copies/ml) |
||||||
---|---|---|---|---|---|---|---|
5.0–7.0 | >7.0 | ||||||
Variable | >0–4.99 | 5.0–7.0 | >7.0 | OR (95% CI)b | p-Valuec | OR (95% CI) | P-Value |
Age (years) | |||||||
<35 | 22 | 128 | 8 | 1.0 | 1.0 | ||
≥35 | 39 | 473 | 53 | 2.2 (1.1–4.2) | 0.02 | 3.5 (1.2–9.7) | 0.02 |
Race | |||||||
White | 15 | 98 | 12 | 1.0 | 1.0 | ||
Hispanic | 9 | 109 | 8 | 1.6 (0.6–4.3) | 0.31 | 0.7 (0.2–2.9) | 0.67 |
Black | 35 | 386 | 39 | 1.4 (0.7–3.0) | 0.39 | 0.7 (0.2–2.0) | 0.50 |
Others | 2 | 8 | 2 | 0.5 (0.1–3.1) | 0.46 | 0.9 (0.1–8.6) | 0.91 |
History of amphetamine use | |||||||
No | 53 | 585 | 59 | 1.0 | 1.0 | ||
Yes | 8 | 15 | 1 | 0.2 (0.0–0.5) | 0.002 | 0.7 (0.0–0.7) | 0.03 |
History of marijuana/hash use | |||||||
No | 46 | 433 | 38 | 1.0 | 1.0 | ||
Yes | 15 | 166 | 21 | 1.3 (0.6–2.9) | 0.45 | 2.6 (1.0–6.9) | 0.06 |
Ever had sex for drugs, money, shelter | |||||||
No | 25 | 239 | 32 | 1.0 | 1.0 | ||
Yes | 36 | 361 | 28 | 0.9 (0.5–1.7) | 0.73 | 0.5 (0.2–1.1) | 0.10 |
Sex with injection drug user | |||||||
No | 22 | 133 | 17 | 1.0 | 1.0 | ||
Yes | 38 | 458 | 43 | 2.1 (1.1–4.0) | 0.03 | 1.4 (0.6–3.3) | 0.51 |
Alcohol use | |||||||
0/wk | 30 | 262 | 28 | 1.0 | 1.0 | ||
<3/wk | 16 | 126 | 10 | 0.9 (0.4–1.9) | 0.81 | 0.5 (0.2–1.5) | 0.23 |
3–13/wk | 9 | 103 | 15 | 1.1 (0.4–2.6) | 0.86 | 1.4 (0.5–4.5) | 0.52 |
13+/wk | 5 | 93 | 6 | 1.9 (0.6–5.6) | 0.27 | 0.8 (0.2–3.7) | 0.78 |
Current smoking | |||||||
No | 20 | 122 | 13 | 1.0 | 1.0 | ||
Yes | 41 | 478 | 47 | 1.7 (0.9–3.4) | 0.11 | 1.9 (0.7–4.9) | 0.21 |
AIDS | |||||||
No | 31 | 400 | 20 | 1.0 | 1.0 | ||
Yes | 30 | 201 | 41 | 0.5 (0.2–0.9) | 0.02 | 2.1 (0.9–5.3) | 0.10 |
HIV therapy | |||||||
None | 20 | 243 | 16 | 1.0 | 1.0 | ||
Mono | 19 | 198 | 23 | 1.1 (0.5–2.5) | 0.74 | 0.9 (0.3–2.8) | 0.91 |
Combo | 16 | 144 | 17 | 0.9 (0.4–2.2) | 0.83 | 1.3 (0.4–4.1) | 0.70 |
HAART | 6 | 14 | 5 | 0.3 (0.1–1.0) | 0.05 | 2.4 (0.5–12.3) | 0.29 |
HIV plasma RNA (copies/ml) | |||||||
<4,000 | 19 | 175 | 15 | 1.0 | 1.0 | ||
4,000–20,000 | 9 | 136 | 10 | 1.4 (0.5–3.4) | 0.50 | 0.7 (0.2–2.6) | 0.64 |
20,000–100,000 | 15 | 141 | 11 | 0.9 (0.4–2.1) | 0.79 | 0.7 (0.2–2.4) | 0.55 |
>100,000 | 17 | 146 | 25 | 0.7 (0.3–1.9) | 0.52 | 1.1 (0.3–4.0) | 0.86 |
CD4 counts(cells/ml) | |||||||
>500 | 19 | 164 | 12 | 1.0 | 1.0 | ||
200–500 | 24 | 267 | 28 | 1.4 (0.6–3.2) | 0.40 | 1.7 (0.6–5.2) | 0.33 |
<200 | 16 | 158 | 17 | 1.8 (0.6–5.6) | 0.29 | 1.7 (0.4–8.0) | 0.48 |
CD8 counts(cells/ml) | |||||||
>1200 | 10 | 114 | 15 | 1.0 | 1.0 | ||
800–1200 | 16 | 168 | 18 | 1.0 (0.4–2.5) | 0.97 | 0.9 (0.3–2.9) | 0.89 |
<800 | 33 | 307 | 24 | 0.7 (0.3–1.7) | 0.41 | 0.3 (0.1–0.8) | 0.02 |
Model includes all variables with P < 0.20 on univariate analysis
Odds ratio (95% confidence interval) from dichotomous logistic regression
P-values < 0.05 are bolded